Penggunaan Heparin Dosis Tinggi pada Pasien COVID-19 dengan ARDS di Unit Perawatan Intensif (ICU) RS Darurat Wisma Atlit
Background: An outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that began in Wuhan, China has spread rapidly in multiple countries of the world and has become a pandemic. The severe acute respiratory syndrome-corona virus-2 (SARS...
Main Author: | Vien Hardiyanti |
---|---|
Format: | Article |
Language: | English |
Published: |
Talenta Publisher
2022-02-01
|
Series: | Scripta Score Scientific Medical Journal |
Subjects: | |
Online Access: | https://talenta.usu.ac.id/scripta/article/view/6293 |
Similar Items
-
Stroke Large Vessel Occlusion pada Serologi COVID-19 Positif
by: Wilson Saputra Wijaya, et al.
Published: (2021-02-01) -
Diagnostic precision of C-reactive protein to albumin ratio for coagulopathy in patients with COVID-19
by: Oğuz Karabay, et al.
Published: (2022-06-01) -
The Role of Heparin in COVID-19: An Update after Two Years of Pandemics
by: Marco Mangiafico, et al.
Published: (2022-05-01) -
The Coagulopathy Bleeding in Disseminated Intravascular Coagulation. Therapy by Heparin and Treatment Plasmapheresis
by: Kurgan M., et al.
Published: (2015-12-01) -
Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
by: Janis Kay Shute
Published: (2023-04-01)